… We included all studies on glucocorticoid therapy for patients diagnosed with COVID-19,
SARS or MERS, without restricting the diagnostic criteria. We included randomized controlled …

… Studies on the efficacy and safety of glucocorticoids in the treatment of COVID-19 emerge
endlessly… the efficacy and safety of glucocorticoids versus usual care or placebo for COVID-19. …

… of COVID-19 patients, … of glucocorticoid remain unclear. Therefore, the purpose of this
network meta-analysis is to analyze the efficacy and safety of glucocorticoids in treating COVID-19 …

… Background: Novel coronavirus pneumonia is a novel kind of … of antiviral therapy
combined with glucocorticoids (GCs) in … treating patients with coronavirus disease 2019 (COVID-19). …

… DX 20 mg IV daily for 5 days followed by 10 mg daily for 5 days Moderate or Severe cases
of COVID-19 Efficacy and Safety of DX vs placebo in mechanically ventilated pts with the …

… and severe hypoxia; NCT04348305); Steroids-SARI (Glucocorticoid therapy for COVID-19
critically ill patients with severe acute respiratory failure; NCT04244591)] were searched by …

… use of corticosteroids in patients with coronavirus disease 2019 (COVID-19). Indirect …
COVID-19, we conducted systematic reviews examining the impact of corticosteroids in COVID-19 …

… Coronavirus Disease 19 (COVID-19) is associated with high morbidity and mortality rates …
approved for the treatment of COVID-19. Among these, glucocorticoids (GCs) have received …

… with severe coronavirus disease 2019 (COVID-19) remain … As estimated, ~20% of the
COVID-19 patients will advance to … efficacy and safety of corticosteroids in COVID-19 patients is …

… Since the start of the coronavirus disease 2019 (COVID-19) pandemic, there … COVID-19.
In this study, we aimed to assess the therapeutic efficacy of glucocorticoids in severe COVID-19. …